Skip to main content

Articles

Perspectives
“I Have a Hunch”
Read More
Practice Management
Resource Utilization and Cost in a Commercially Insured Population with Schizophrenia
Stakeholder Perspective
Schizophrenia: “The Forgotten Illness”?
Read More
Original Research
Fixed-Dose Combination Gel of Adapalene and Benzoyl Peroxide plus Doxycycline 100 mg versus Oral Isotretinoin for the Treatment of Severe Acne: Efficacy and Cost Analysis
Stakeholder Perspective
Evaluating Treatments for Acne: It’s Time to “Sweat” the Smaller Things
Read More
Original Research
Outcomes Associated with 5-HT3-RA Therapy Selection in Patients with Chemotherapy-Induced Nausea and Vomiting: A Retrospective Claims Analysis
Stakeholder Perspective
Value of Selecting the Best Antiemetic Prophylactic Agent for Patients Using Chemotherapy
Read More
Press Releases
IMBRUVICA™ Approved For Previously Treated Chronic Lymphocytic Leukemia; Immediately Available Through Onco360®
Read More
2012 Annual Index
Read More
Press Releases
Mekinist™ (trametinib) & Tafinlar® (dabrafenib) Approved In Combination; Both Limited Distribution Products Immediately Available Via Onco360®
Read More
FDA Approvals
Brintellix (Vortioxetine) Receives FDA Approval for the Treatment of Major Depressive Disorder
Read More
FDA Approvals
Injectafer (Ferric Carboxymaltose Injection) Receives FDA Approval for the Treatment of Iron-Deficiency Anemia
Read More
Practice Management
Insurance Companies’ Perspectives on the Orphan Drug Pipeline
Stakeholder Perspective
Breakthrough Therapy, or Breakthrough Pricing?
Read More
Page 161 of 245
Results 1601 - 1610 of 2441